12:00 AM
 | 
Oct 27, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

PhiloGene Inc.

Summit, N.J.

Technology: Anti-angiogenic VEGF proteins

Disease focus: Cancer, ophthalmic

Clinical status:...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >